Co-Authors
This is a "connection" page, showing publications co-authored by Samy Hadjadj and Bertrand Cariou.
Connection Strength
1.978
-
Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study. Diabetes Res Clin Pract. 2021 05; 175:108695.
Score: 0.232
-
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study. Diabetes Metab. 2021 03; 47(2):101202.
Score: 0.227
-
Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399-1407. Diabetes Care. 2020 10; 43(10):e163-e164.
Score: 0.226
-
Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 09; 63(9):1953-1957.
Score: 0.225
-
Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]. Diabetologia. 2020 11; 63(11):2491-2494.
Score: 0.225
-
Euglycaemic ketoacidosis during gestational diabetes with concomitant COVID-19 infection. Diabetes Metab. 2021 03; 47(2):101181.
Score: 0.224
-
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 08; 63(8):1500-1515.
Score: 0.221
-
Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study. Eur J Endocrinol. 2021 Jul 05; 185(2):299-311.
Score: 0.060
-
Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study. Diabetologia. 2021 04; 64(4):778-794.
Score: 0.058
-
Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study. Diabetes Obes Metab. 2021 05; 23(5):1162-1172.
Score: 0.058
-
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19. Diabetes Metab. 2021 09; 47(5):101216.
Score: 0.057
-
Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO study. Diabetes Obes Metab. 2021 02; 23(2):391-403.
Score: 0.057
-
Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study. Diabetes Care. 2020 11; 43(11):e174-e177.
Score: 0.056
-
No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: The cross-sectional VARDIA study. J Diabetes Complications. 2019 08; 33(8):554-560.
Score: 0.051